0000899243-20-018356.txt : 20200702 0000899243-20-018356.hdr.sgml : 20200702 20200702191501 ACCESSION NUMBER: 0000899243-20-018356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waynick Denelle J CENTRAL INDEX KEY: 0001816440 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 201011569 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER NAME: FORMER CONFORMED NAME: Waynick Denelle DATE OF NAME CHANGE: 20200629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-01 0 0001552451 MyoKardia, Inc. MYOK 0001816440 Waynick Denelle J C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 0 1 0 0 General Counsel Stock Option (Right to Buy) 93.84 2020-07-01 4 A 0 80000 0.00 A 2030-06-30 Common Stock 80000 80000 D Restricted Stock Units 2020-07-01 4 A 0 25000 0.00 A Common Stock 25000 25000 D 25% of the shares subject to this option shall vest and become exercisable on June 29, 2021, and the remainder shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested shares underlying the option will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in four annual installments after July 1, 2020, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested units will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy. /s/ Denelle J. Waynick 2020-07-02